Holen Sie sich die Stockscreener-App
19.77
0.18%
-0.035
Handel nachbörslich:
19.90
0.13
+0.66%
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says - marketscreener.com
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating By Investing.com - Investing.com Nigeria
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating - Investing.com
Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target - Yahoo Finance
Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September By Investing.com - Investing.com Canada
Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September - Investing.com India
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history - Yahoo Finance UK
Form 4 Amneal Pharmaceuticals Inc Class A For: 22 September By Investing.com - Investing.com Nigeria
Amneal: Even My Bull Case Barely Justifies $20/Share (NASDAQ:AMRX) - Seeking Alpha
Amneal Pharmaceuticals Inc (AMRX) Shares Surge 7.8% -- What GF S - GuruFocus
Amneal Pharmaceuticals Director Kevin J. Buchi Transfers 20,445 Shares to Trust - kalkinemedia.com
Why Is Amneal (AMRX) Stock Rocketing Higher Today - Yahoo Finance
Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he oversees - Stock Titan
Amneal Pharmaceuticals Jumps 6.4% After Barclays Maintains Overweight - AlphaStreet
Update: Amneal Pharmaceuticals Shares Rise After FDA Approval for Lanreotide Injection - Yahoo Finance
Amneal Pharmaceuticals stock hits 52-week high at 19.32 USD - Investing.com
Amneal Launches Its Generic Lanreotide Immediately While the Brand Still Posts Nearly a Billion in US Sales - Medical Daily
Amneal Pharmaceuticals stock gains after FDA approval for lanreotide injection - AD HOC NEWS
Amneal receives FDA approval for generic lanreotide injection By Investing.com - Investing.com Nigeria
AMRX Stock Advances As Generic To Ipsen’s Hormone Shot Gets FDA Nod - Yahoo Finance
Stocks to Watch : Paramount Skydance, Warner Bros. Discovery, Accenture, Amneal Pharmaceuticals - marketscreener.com
Amneal Pharmaceuticals Secures FDA Approval for Lanreotide Injection - Yahoo Finance
Amneal receives FDA approval for generic lanreotide injection - Investing.com
An injection for three conditions launches immediately after FDA approval - Stock Titan
Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains? - Eastern Progress
Amneal Pharmaceuticals Inc. (AMRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Amneal Pharmaceuticals Inc (AMRX) Stock Down 3.3% but Still Over - GuruFocus
Insider Unloading: KEVIN BUCHI Sells Options, Realizes $54K - Benzinga
Kentucky Gov. Andy Beshear visits Amneal's Glasgow facility - goSkagit
Amneal Pharmaceuticals, Inc.Class A Common Stock (NQ: AMRX - The Chronicle-Journal
Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target - marketscreener.com
Does Amneal’s New US$523 Million Shelf Registration Reframe Its Capital Allocation Story for AMRX? - simplywall.st
Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)? - Yahoo Finance
Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats - Yahoo Finance
Amneal Pharmaceuticals (AMRX) Stock Sees Modest Fair Value Lift On Launch Optimism - Yahoo Finance
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns - Reuters
Amneal Pharmaceuticals files prospectus for sale of up to 28.9 million shares - scanx.trade
Amneal Pharmaceuticals (AMRX) Following Its Biosimilars Push And The Fair Value Debate - simplywall.st
Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX) - Yahoo Finance
Amneal Pharmaceuticals Says US FDA Approves Romidepsin Injection Solution - Moomoo
J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $22 - Moomoo
Amneal builds end-to-end biosimilars capacity in the U.S. - Chain Drug Review
Amneal Pharmaceuticals (AMRX) Stock Looks Fairly Valued But Earnings Still Look Rich - sahmcapital.com
Amneal (AMRX) Results Review: Profit Per Share Clears Its Benchmark in Latest Trading; Closing Reaction: The Share Price Adds 1.87% in the Current UpdateProfit Warning Alert - Vinanet
Amneal (AMRX) Earnings Report: EPS Beats Its Estimate in Latest Trading; The Market Price Declines 1.25% in the Latest SessionDiluted EPS Report - vinanet.vn
STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Business Wire
Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar - Yahoo Finance
Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance - Sahm
Is Amneal Pharmaceuticals (AMRX) Fairly Valued After A 3.5x Return? - Yahoo Finance
AMRX Q2 2026 Earnings: Strong EPS Beat Drives 5.1% RallyEarnings Revision Upgrade - vinanet.vn
Amneal Pharmaceuticals Director John Kiely Sells 50,000 Shares and Donates 10,000 Shares on August 13, 2026 - Kalkine Media
A Look at Amneal Pharmaceuticals Inc (AMRX) After 5.1% Gain -- G - GuruFocus
Insider Selling: Amneal Pharmaceuticals (NASDAQ:AMRX) Director Sells $882,000.00 in Stock - MarketBeat
Amneal Pharmaceuticals (AMRX) director sells 50,000 shares, gifts 10,000 to charity - Stock Titan
Sell Alert: Nikita Shah Cashes Out $2.56M In Amneal Pharmaceuticals Stock - Benzinga
Amneal Pharmaceuticals(AMRX.US) Officer Sells US$3.77 Million in Common Stock - Moomoo
Nikita Shah Sells 146,403 Shares of Amneal Pharmaceuticals (NASDAQ:AMRX) Stock - MarketBeat
Insider Selling: Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells 6,613 Shares - MarketBeat
0.41%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):